ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
ISTA Pharmaceuticals, Inc, was a rapidly growing specialty pharmaceutical company developing, marketing and selling products in the U.S. and Puerto Rico. It was the fourth largest branded prescription eye care business in the U.S. and had an emerging allergy drug franchise. Its products treated ocular inflammation and pain, glaucoma, dry eye and ocular allergies. It had a U.S. sales force of more than 165 representatives calling on ophthalmologists, optometrists and allergists. The four key products included: BROMDAY (bromfenac ophthalmic solution) 0.09% for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions BEPREVE (bepotastine besilate ophthalmic solution) 1.5% for the treatment of ocular itching associated with allergic conjunctivitis ISTALOL (timolol maleate ophthalmic solution) 0.05% for the treatment of glaucoma VITRASE (hyaluronidase injection) ovine, 200 USP units/ml for use as a spreading agent In June of 2012, ISTA was acquired by Bausch + Lomb and now operates under the Pharmaceutical business of Bausch + Lomb. In July of 2013, Bausch + Lomb was acquired by Valeant.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
ISTA Pharmaceuticals, Inc, was a rapidly growing specialty pharmaceutical company developing, marketing and selling products in the U.S. and Puerto Rico. It was the fourth largest branded prescription eye care business in the U.S. and had an emerging allergy drug franchise. Its products treated ocular inflammation and pain, glaucoma, dry eye and ocular allergies. It had a U.S. sales force of more than 165 representatives calling on ophthalmologists, optometrists and allergists. The four key products included: BROMDAY (bromfenac ophthalmic solution) 0.09% for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions BEPREVE (bepotastine besilate ophthalmic solution) 1.5% for the treatment of ocular itching associated with allergic conjunctivitis ISTALOL (timolol maleate ophthalmic solution) 0.05% for the treatment of glaucoma VITRASE (hyaluronidase injection) ovine, 200 USP units/ml for use as a spreading agent In June of 2012, ISTA was acquired by Bausch + Lomb and now operates under the Pharmaceutical business of Bausch + Lomb. In July of 2013, Bausch + Lomb was acquired by Valeant.
bausch.com
50 Technology Drive Irvine, CA 92618, US
Details
Year founded
2000
Revenue
500M-1B
Employees
5001-10000
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- BEPREVE
- BROMDAY
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Bausch + Lomb surgical product portfolio
- Pharmaceutical packaging machines for ampoules, bottles, vials, syringes and cartridges
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that ista pharmaceuticals products now under bausch + lomb which was acquired by valeant is not ramping up production.
Target industries
Employees working in ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
Locations (1)
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
50 Technology Drive Irvine, CA 92618, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) offer?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) offers a range of services and capabilities, including BEPREVE.
What kind of equipment does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) use?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) uses a variety of equipment, including Bausch + Lomb surgical product portfolio.
What are the target industries of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) serves several industries, including the medical industry.
How many locations does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) operate?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) operates from a single location at 50 technology drive, irvine, california 92618, united states.
Where are the headquarters of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?
The headquarters of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) are located in 50 technology drive, irvine, california 92618, united states.
What is the NAICS code for ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?
The NAICS code for ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) is 3254.
How many employees does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) have?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has 5449 employees.
What is the official website of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?
The official website of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) is https://www.bausch.com/.
When was ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) founded?
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) was founded in 2000.